Podcast Episodes
Back to SearchSpacing the Rectum! With Peter Orio & Shankar Siva
What is a rectal spacer and do they help reduce side-effects from prostate radiation??! That's today's topic on GU Cast. Renu caught up with rectal s…
2 years, 6 months ago
The European Urology Podcast is coming soon!!
Here's a quick plug for another podcast that GU Cast is very happy to support!
Launching in September 2023, the European Urology Podcast is a new mont…
2 years, 6 months ago
Shiny Happy Editors talk Impact Factors
Major scientific journals only change their Editor-in-Chief every 8-10 years so it's quite a big deal when it happens! Today we chat with Professor A…
2 years, 6 months ago
GU Cast hosts do battle at ANZUP ASM!!
Declan and Renu as you haven't seen them before! They leave their cosy podcast studio to do battle at the Australia & New Zealand Urogenital & Prost…
2 years, 7 months ago
Remembering Christchurch | A GU Cast Special
This, our 100th episode, is a very special GU Cast, in which we remember the devastating 2011 Christchurch earthquake, which hit just as the Urologic…
2 years, 7 months ago
Alpha PSMA & New Targets in Prostate Cancer | ProsTIC/PCF Global Webinar
This is for hardcore PSMA aficionados!! This is the 7th of our ProsTIC/Prostate Cancer Foundation Global Webinars focussing on all things PSMA theran…
2 years, 7 months ago
Avoiding cystectomy for high-grade bladder cancer
Dr Sima Porten from the University of California San Francisco (UCSF), was in Melbourne this week for the ANZUP Annual Scientific Meeting (more from …
2 years, 7 months ago
Bladder cancer bonanza | With Dr Sia Daneshmand
Two cracking bladder cancer studies to discuss on GU Cast today (in our brand new GU Cast studio)! We are joined by Dr Sia Daneshmand, Urologist and …
2 years, 8 months ago
Is SABR the best way to radiate the prostate??!
Stereotactic Ablative Body Radiotherapy (SABR) has been a great tool for managing low volume metastatic prostate cancer for a few years now. One or t…
2 years, 8 months ago
ARPIs reimbursed for mHSPC | Urologists take note!
With approvals and reimbursement increasing all the time for the use of AR pathway inhibitors (ARPIs) in metastatic hormone-sensitive prostate cancer…
2 years, 8 months ago